Literature DB >> 23742284

Updating on understanding and managing chronic wound.

Nanjin J Park1, Latricia Allen, Vickie R Driver.   

Abstract

The art of healing wounds is quite complex. It requires the patient's local condition in conjunction with their systemic condition to provide the most ideal wound environment. As wound care is expanding with advances in technology, we are facing a variety of different wound care products based on an assortment of bioengineered skin substances, growth factors, oxygen therapies, low frequency ultrasound and even low energy light. While these emerging evidence-based treatments prove to be promising in improving clinical outcomes and quality of life, it challenges providers to provide cost-effective treatment plans. The goal of this paper is to introduce a discussion regarding practical clinical application of various forms of advanced wound technologies in order to optimize the art of wound healing.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23742284     DOI: 10.1111/dth.12052

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  4 in total

1.  [Wound healing in the elderly].

Authors:  S A Eming; M Wlaschek; K Scharffetter-Kochanek
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

Review 2.  Therapeutic strategies for enhancing angiogenesis in wound healing.

Authors:  Austin P Veith; Kayla Henderson; Adrianne Spencer; Andrew D Sligar; Aaron B Baker
Journal:  Adv Drug Deliv Rev       Date:  2018-09-26       Impact factor: 15.470

3.  Glu-Trp-ONa or its acylated analogue (R-Glu-Trp-ONa) administration enhances the wound healing in the model of chronic skin wounds in rabbits.

Authors:  Maxim A Shevtsov; Larisa V Smagina; Tatiana A Kudriavtceva; Sergey V Petlenko; Irina V Voronkina
Journal:  Drug Des Devel Ther       Date:  2015-03-20       Impact factor: 4.162

4.  Towards a systems approach for chronic diseases, based on health state modeling.

Authors:  Michael Rebhan
Journal:  F1000Res       Date:  2017-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.